HWKN Hawkins, Inc.
Hawkins, Inc. engaged in the distribution, blending, and manufacture of chemicals and specialty ingredients for a wide variety of industries. It operates through the following segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment provides g industrial chemicals, products, and services to the agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. The Water Treatment segment offers chemicals, equipment, and solutions for potable water, municipal, industrial wastewater, industrial process water, and non-residential swimming pool water. The Health and Nutrition segment comprises of the ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, health, and wellness products. The company was founded by Howard Hawkins in 1938 and is headquartered in Roseville, MN.
Company profile
Ticker
HWKN
Exchange
CEO
Patrick H. Hawkins
Employees
Incorporated in
Location
Fiscal year end
Industry (SEC)
Former names
Hawkins Chemical Inc
SEC CIK
Corporate docs
IRS number
410771293
HWKN stock data
()
Calendar
31 Jul 19
17 Oct 19
29 Mar 20
News
Company financial data Financial data
| Quarter (USD) | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|
| Revenue | 147.34M | 133.05M | 128.15M | 145.32M | |
| Net income | 9.81M | 3.77M | 4.13M | 7.41M | |
| Diluted EPS | 0.92 | 0.35 | 0.39 | 0.69 | |
| Net profit margin | 6.66% | 2.83% | 3.22% | 5.10% | |
| Operating income | 13.96M | 5.79M | 6.72M | 10.83M | |
| Net change in cash | -3.59M | 1.9M | 3.26M | -1.14M | |
| Cash on hand | 5.61M | 9.2M | 7.3M | 4.04M | |
| Cost of revenue | 118.54M | 112.38M | 107.12M | 119.55M |
| Annual (USD) | Mar 19 | Mar 15 |
|---|---|---|
| Revenue | 556.33M | 364.02M |
| Net income | 24.43M | 19.21M |
| Diluted EPS | 2.28 | 1.81 |
| Net profit margin | 4.39% | 5.28% |
| Operating income | 36.82M | 30.42M |
| Net change in cash | -9.44M | |
| Cash on hand | 9.2M | 18.64M |
| Cost of revenue | 460.39M | 298.23M |
Financial data from Hawkins earnings reports
Financial report summary
?Risks
- Environmental problems at any of our facilities could result in significant unexpected costs.
- Our food, pharmaceutical and nutritional products are subject to government regulation, both in the United States and abroad, which could increase our costs significantly and limit or prevent the sale of such products.
- Our businesses expose us to potential product liability claims and recalls, which could adversely affect our financial condition and performance.
- Demand for our food and nutritional products is highly dependent upon consumers’ perception of the safety and quality of our products, our customers’ products as well as similar products distributed by other companies, and adverse publicity and negative public perception regarding particular ingredients or products or the nutraceuticals industry in general could limit our ability to increase revenue and grow that portion of our business.
- The insurance that we maintain may not fully cover all potential exposures.
- Failure to comply with the covenants under our credit facility may have a material adverse effect.
- Impairment to the carrying value of our goodwill or other intangible assets could adversely affect our financial condition and consolidated results of operations.
Management Discussion
- We derive substantially all of our revenues from the sale of chemicals and specialty ingredients to our customers in a wide variety of industries. We began our operations primarily as a distributor of bulk chemicals with a strong customer focus. Over the years, we have maintained the strong customer focus and have expanded our business by increasing our sales of value-added chemical and specialty ingredients, including manufacturing, blending, and repackaging certain products.
- We focus on total profitability dollars when evaluating our financial results as opposed to profitability as a percentage of sales, as sales dollars tend to fluctuate, particularly in our Industrial and Water Treatment segments, as raw material costs rise and fall. The costs for certain of our raw materials can rise or fall rapidly, causing fluctuations in gross profit as a percentage of sales.
- We use the last in, first out (“LIFO”) method for valuing the majority of our inventory in our Industrial and Water Treatment segments, which causes the most recent product costs for those products to be recognized in our income statement. The valuation of LIFO inventory for interim periods is based on our estimates of fiscal year-end inventory levels and costs. The LIFO inventory valuation method and the resulting cost of sales are consistent with our business practices of pricing to current chemical raw material prices. Inventories in the Health and Nutrition segment are valued using the first-in, first-out (“FIFO”) method.
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Good
|
|
New words:
accrued, attributable, Benchmark, classification, commencement, commencing, component, conformity, consent, convention, cumulative, demand, drove, employee, estate, exemption, exercise, expedient, extend, February, flooding, heavy, ICE, identification, implicit, inception, initial, jointly, key, land, larger, lender, lessee, Mississippi, model, objection, objective, option, order, package, pattern, phase, plant, practical, prevailing, primary, qualified, readily, real, renewal, renewing, River, ROU, row, shortage, sit, successor, supply, syndicated, technology, temporary, transition, warehouse, worldwide
Removed:
arising, Codification, consisting, core, determine, discounted, enacted, entity, expansion, extension, favorable, finalized, fourth, historic, improved, January, legislation, mandatory, mix, provisional, qualitative, quantitative, quantity, reduced, retained, revalued, scheduled, seek, shift, slightly, storage, variable
Financial reports
10-Q
2020 Q1
Quarterly report
31 Jul 19
10-K
2019 FY
Annual report
23 May 19
10-Q
2019 Q3
Quarterly report
6 Feb 19
10-Q
2019 Q2
Quarterly report
31 Oct 18
10-Q
2019 Q1
Quarterly report
2 Aug 18
10-K
2018 FY
Annual report
31 May 18
10-Q
2018 Q3
Quarterly report
8 Feb 18
10-Q
2018 Q2
Quarterly report
2 Nov 17
10-Q
2018 Q1
Quarterly report
9 Aug 17
10-K
2017 FY
Annual report
1 Jun 17
Current reports
8-K
Submission of Matters to a Vote of Security Holders
5 Aug 19
8-K
Hawkins, Inc. Reports
31 Jul 19
8-K
Hawkins, Inc. Reports
23 May 19
8-K
Hawkins, Inc. Announces Increase In Number of Shares Authorized Under Share Repurchase Program
7 Feb 19
8-K
Hawkins, Inc. Reports
6 Feb 19
8-K
Hawkins, Inc. Amends and Extends Credit Agreement
3 Dec 18
8-K
Second Quarter Fiscal 2019 Results
31 Oct 18
8-K
Submission of Matters to a Vote of Security Holders
7 Aug 18
8-K
First Quarter Fiscal 2019 Results
2 Aug 18
8-K
Fourth Quarter, Fiscal 2018 Results
30 May 18
Registration and prospectus
S-8
Registration of securities for employees
2 Nov 18
S-8
Registration of securities for employees
6 Jun 11
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Jun 11
S-8
Registration of securities for employees
11 Mar 11
S-8
Registration of securities for employees
2 Mar 05
S-8
Registration of securities for employees
3 May 02
Proxies
DEFR14A
Filing
17 Jul 19
DEF 14A
Definitive proxy
28 Jun 19
DEF 14A
Definitive proxy
29 Jun 18
DEF 14A
Definitive proxy
30 Jun 17
DEF 14A
Definitive proxy
1 Jul 16
DEFA14A
Additional proxy soliciting materials
24 Jun 15
DEF 14A
Definitive proxy
1 Jul 14
DEF 14A
Definitive proxy
24 Jun 13
DEF 14A
Definitive proxy
27 Jun 12
DEF 14A
Definitive proxy
22 Jun 11
Other
UPLOAD
Letter from SEC
19 Jun 09
CORRESP
Correspondence with SEC
18 Jun 09
UPLOAD
Letter from SEC
17 Jun 09
UPLOAD
Letter from SEC
26 Mar 09
CORRESP
Correspondence with SEC
9 Mar 09
UPLOAD
Letter from SEC
23 Feb 09
UPLOAD
Letter from SEC
16 May 07
CORRESP
Correspondence with SEC
14 May 07
UPLOAD
Letter from SEC
9 May 07
CORRESP
Correspondence with SEC
25 Apr 07